[Diagnosis and treatment of glucocorticoid-induced osteoporosis in collagen vascular disease].
Kawano
Seiji
S
Department of Clinical Laboratory, Kobe University Hospital.
Kumagai
Shunichi
S
D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001842:Bone and Bones / Q000378:metabolism; D002762:Cholecalciferol / Q000627:therapeutic use; D003095:Collagen Diseases / Q000150:complications*; D004164:Diphosphonates / Q000627:therapeutic use*; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology; D010024:Osteoporosis / Q000209:etiology* / Q000378:metabolism / Q000517:prevention & control*; D024482:Vitamin K 2 / Q000627:therapeutic use
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D005938:Glucocorticoids; D024482:Vitamin K 2; D002762:Cholecalciferol